Axcella previews long Covid registrational trial plans in UK and US
Axcella in discussions with UK regulators for a new long Covid trial, CEO says, following Phase IIa results announced this…
By
UK News
Latest in
UK News
Alzheimer’s disease: charting amyloid theory trials amidst another controversy
After reports of possible image fabrication in studies supporting the amyloid theory for Alzheimer’s disease, we break down the slate…
By
Arcellx shares Phase III CAR-T design plans in earlier line multiple myeloma
While a Phase II CART-ddBCMA trial in later-line multiple myeloma has yet to start, Arcellx is already planning a Phase…
By
Where’s the demand in human challenge clinical trials?
The Covid-19 pandemic put human challenge trials in the spotlight, drawing attention to this design’s possibilities in infectious disease studies.
By
Aristea contemplates Phase III design for rare skin disease drug
As Aristea develops a palmoplantar pustulosis treatment, US and European regulators indicate different primary endpoint preferences.
By
Cullinan Oncology previews Phase IIb NSCLC trial planned for end of year start
CMO Jeff Jones shares Cullinan’s blueprint for an upcoming Phase IIb trial recruiting non-small cell lung cancer patients with EGFR…
By
Fauci: long Covid-19 trial endpoints ‘absolutely have to be standardised’
Clinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a National…
By
Overcoming obstacles in trans and nonbinary participation in clinical trials
The clinical trials sector can make small changes to make transgender, nonbinary individuals feel safe to join studies.
By